Resident Companies in Action: AlgometRx With Children’s National Hospital’s Innovation Day and Showcase approaching on May 31, the team at Johnson & Johnson Innovation – JLABS @ Washington, DC spoke [….]
Resident Companies in Action: AlgometRx
Greater Philadelphia Q4 2022 News Recap – December was a Pivotal Month for Cellicon Valley Companies
Cellicon Valley companies closed out 2022 with a roar. Madrigal Pharmaceuticals announced a breakthrough in NASH that could result in the first-approved drug for that disease. Galera Therapeutics closed out December with plans to seek approval for its severe oral mucositis therapy.
JLL Arranges Major Capitalization for Gattuso Development’s New Philadelphia Life Sciences Project
JLL’s Capital Markets group announced today that it has arranged a $290 million construction loan that will allow project partners Gattuso Development Partners and Vigilant Holdings of New York to build a state-of-the-art research facility at 3201 Cuthbert Street, an 11-story life sciences development in the heart of Philadelphia’s University City submarket.
2500 League Island Boulevard: The Future of Life Sciences Manufacturing Takes Shape in the Philly Navy Yard
A new, purpose-built facility at 2500 League Island Boulevard in the heart of Philadelphia will bring much-needed world-class manufacturing and R&D space to a burgeoning life sciences ecosystem. The large building, 130,000 ft2 with 30 ft clear height, will accommodate the unique demands of life sciences manufacturing, as will its large floor slabs and abundant roof-top utilities.
Industry Leaders Share Optimism on the Region’s Life Sciences Economic Outlook Amid Recession Concerns
To discuss how the Biohealth Capital Region would fare out in a potential recession, and whether it can actually avoid one, the I-270 Innovation Labs brought together an outstanding group of regional experts from across key sectors connected to both industries.
Despite Rocky Biotech Bear Market, the BioHealth Capital Region Holds Fast and Forges Ahead
The seas have been rough this year for the biotech and life sciences market, with funding scarcity and layoffs abound. The BioHealth Capital Region (BHCR) has braced the storm, though, holding tight to its fourth-place ranking on the Genetic & Engineering News (GEN) Top 10 Biopharma Clusters list. Alex Phillipidus, Senior Business Editor for GEN, gave the update at the eighth annual BioHealth Capital Region Forum.
Guardian Realty Investors Announce New Life Sciences Laboratory
Guardian Realty Investors, LLC announced their new life sciences lab location at 20400 Observation Drive, Germantown MD, known as OBSERVATION LABS. This re-imagined former industrial and technology building will also provide extraordinary amenities, gathering spaces and best-in-class finish levels. Guardian is a developer and operator of office, multi-family and specialized facilities in the Washington, DC Metropolitan Area.
Montgomery County’s Life Science Ecosystem Continues to Surge Amidst Bear Market
Bisnow recently held a webinar titled “Montgomery County Life Sciences Surge,” sponsored by the Montgomery County Economic Development Corporation (MCEDC), on August 11. Brad Stewart, Senior Vice President of Business Development at MCEDC, posed questions to real estate professional panelists about the future of Montgomery County’s life science environment.
BioHealth Capital Region Retains Strong Grip on No. 4 Spot of Top 10 U.S. Biopharma Hubs Eyes Third Spot by 2023
As a life sciences cluster, the BioHealth Capital Region is poised to become a top-three cluster in the Genetic Engineering & Biotechnology News (GEN) Top 10 Biopharma Clusters ranking on the strengths of early-stage companies becoming commercial successes and the construction of millions of square feet of new wet lab space.
Q&A: JLL’s Pete Briskman on Montgomery County’s Life Science Market – Commercial Observer
With the highest concentration of Ph.D.s in the country — plus proximity to the government, top-tier medical universities and numerous biomedical companies — the life sciences sector in Montgomery County is ripe to accelerate in the coming years.
There’s also a rising interest among building owners in converting assets to lab, research and biotech space throughout the D.C. region.
SEE ALSO: Investor Blackwells Comes Out Against Sam Zell’s Acquisition of Monmouth
Pete Briskman, JLL’s executive managing director and co-lead for the firm’s mid-Atlantic life sciences practice, spoke with Commercial Observer about why the area is so popular and his belief that demand will continue in the months and years ahead.
Commercial Observer: How would you portray Montgomery County’s life sciences business as we stand here in the first week of August?